Entecavir in the treatment of chronic hepatitis B in kidney transplantation

Journal of Hepatology

Volumn 56, Issue 4, 2012, Pages 997-998

  Ridruejo, Ezequiel ^a,b   Adrover, Raúl ^c   Mandó, Oscar G ^a   Silva, Marcelo O ^b  

^a CEMIC   (Argentina)

^b UNIVERSIDAD AUSTRAL   (Argentina)

^c Hepatology Section   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ANTIBODY TITER; CHRONIC HEPATITIS; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; HEMODIALYSIS; HEPATITIS B; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LETTER; MALE; PRIORITY JOURNAL; SEROCONVERSION; TREATMENT OUTCOME; VIRUS LOAD;

HEPATITIS, VIRAL, HUMAN; HUMANS; TRANSPLANTS;

EID: 84858701309     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.09.019     Document Type: Letter

References (5)

1. A. Vallet-Pichard, H. Fontaine, V. Mallet, and S. Pol Viral hepatitis in solid organ transplantation other than liver J Hepatol 55 2011 474 482
2. N. Kamar, O. Milioto, L. Alric, L. El Kahwaji, O. Cointault, and L. Lavayssiere Entecavir therapy for adefovir-resistant hepatitis B virus infection in kidney and liver allograft recipients Transplantation 86 2008 611 614
3. E. Ridruejo, R. Adrover, C. Alonso, O.G. Mandó, and M.O. Silva Entecavir in the treatment of chronic hepatitis B in end stage renal disease and kidney transplantation Dial Transplant 39 2010 397 400
4. KDIGO Clinical practice guideline for the care of kidney transplant recipients Am J Transplant 9 2009 S52 S57
5. European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of chronic hepatitis B J Hepatol 50 2009 227 242